The Australian Mohs database, part II: Periocular basal cell carcinoma outcome at 5-year follow-up

Ophthalmology

Volumn 111, Issue 4, 2004, Pages 631-636

  Malhotra, Raman ^a   Huilgol, Shyamala C ^a   Huynh, Nghi T ^b   Selva, Dinesh ^a,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b SKIN AND CANCER FOUNDATION AUSTRALIA   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASAL CELL CARCINOMA; CANCER INVASION; CANCER LOCALIZATION; CANCER SIZE; CASE STUDY; CHEMOSURGERY; CLINICAL TRIAL; CONFIDENCE INTERVAL; DATA BASE; EYELID CARCINOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOWER EYELID; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME; UPPER EYELID;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CARCINOMA, BASAL CELL; DATABASES, FACTUAL; EYELID NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOHS SURGERY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 1842581342     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2003.11.004     Document Type: Article

References (30)

1. Green A., Battistutta D. Incidence and determinants of skin cancer in a high-risk Australian population. Int J Cancer. 46:1990;356-361.
2. Rowe D.E., Carroll R.J., Day C.L. Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma implications for patient follow-up. J Dermatol Surg Oncol. 15:1989;315-328.
3. Rowe D.E., Carroll R.J., Day C.L. Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol. 15:1989;424-431.
4. Cutler S.J., Ederer F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 8:1958;699-712.
5. McGovern T.W., Leffell D.J. Mohs surgery the informed view. Arch Dermatol. 135:1999;1255-1259.
6. Malhotra R, Huilgol SC, Huynh NT, Selva D. The Australian Mohs database, part I: periocular basal cell carcinoma experience over 7 years. Ophthalmology 2004;111:624-30.
7. Margo C.E., Waltz K. Basal cell carcinoma of the eyelid and periocular skin. Surv Ophthalmol. 38:1993;169-192.
8. Telfer N.R., Colver G.B., Bowers P.W. Guidelines for the management of basal cell carcinoma. Br J Dermatol. 141:1999;415-423.
9. Mohs F.E. Micrographic surgery for the microscopically controlled excision of eyelid cancers. Arch Ophthalmol. 104:1986;901-909.
10. Robins P., Rodriguez-Sains R., Rabinovitz H., Rigel D. Mohs surgery for periocular basal cell carcinomas. J Dermatol Surg Oncol. 11:1985;1203-1207.
11. Anderson R.L., Ceilley R.I. A multispecialty approach to the excision and reconstruction of eyelid tumors. Ophthalmology. 85:1978;1150-1163.
12. Anderson R.L. Mohs' micrographic technique. Arch Ophthalmol. 104:1986;818-819.
13. Miller P.K., Roenigk R.K., Brodland D.G., Randle H.W. Cutaneous micrographic surgery Mohs procedure. Mayo Clin Proc. 67:1992;971-980.
14. Arlette J.P., Carruthers A., Threlfall W.J., Warshawski L.M. Basal cell carcinoma of the periocular region. J Cutan Med Surg. 2:1998;205-208.
15. Callahan A., Monheit G.D., Callahan M.A. Cancer excision from eyelids and ocular adnexa the Mohs fresh tissue technique and reconstruction. Cancer. 32:1982;322-329.
16. Callahan A. Mohs technique. Cancer. 36:1986;373-375.
17. Cook B.E. Jr, Bartley G.B. Treatment options and future prospects for the management of eyelid malignancies an evidence-based update. Ophthalmology. 108:2001;2088-2098.
18. Breuninger H., Dietz K. Prediction of subclinical tumor infiltration in basal cell carcinoma. J Dermatol Surg Oncol. 17:1991;574-578.
19. Wolf D.J., Zitelli J.A. Surgical margins for basal cell carcinoma. Arch Dermatol. 123:1987;340-344.
20. Downes R.N., Walker N.P., Collin J.R. Micrographic (MOHS') surgery in the management of periocular basal cell epitheliomas. Eye. 4:1990;160-168.
21. Frank H.T. Frozen section control of excision of eyelid basal cell carcinomas 8 1/2 years' experience. Br J Ophthalmol. 73:1989;328-332.
22. Older J.J., Quickert M.H., Beard C. Surgical removal of basal cell carcinoma of the eyelids utilizing frozen section control. Trans Am Acad Ophthalmol Otolaryngol. 79:1975;658-663.
23. Doxanas M.T., Green W.R., Iliff C.E. Factors in the successful surgical management of basal cell carcinoma of the eyelid. Am J Ophthalmol. 91:1981;729-736.
24. Chalfin J., Putterman A.M. Frozen section control in the surgery of basal cell carcinoma of the eyelid. Am J Ophthalmol. 87:1979;802-809.
25. Abide J.M., Nahai F., Bennet R.G. The meaning of surgical margins. Plast Reconstr Surg. 73:1984;492-497.
26. Pieh S., Kuchar A., Novak P., et al. Long-term results after surgical basal cell carcinoma excision in the eyelid region. Br J Ophthalmol. 83:1999;85-88.
27. David D.B., Gimblett M.L., Potts M.J., Harrad R.A. Small margin (2 mm) excision of peri-ocular basal cell carcinoma with delayed repair. Orbit. 18:1999;11-15.
28. Ghauri R.R., Gunter A.A., Weber R.A. Frozen section analysis in the management of skin cancers. Ann Plast Surg. 43:1999;156-160.
29. Wong V.A., Marshall J.A., Whitehead K.J., et al. Management of periocular basal cell carcinoma with modified en face frozen section controlled excision. Ophthal Plast Reconstr Surg. 18:2002;430-435.
30. Feasel A.M., Brown T.J., Bogle M.A., et al. Perineural invasion of cutaneous malignancies. Dermatol Surg. 27:2001;531-542.